Redox platforms in cancer drug discovery and development

KD Tew, DM Townsend - Current opinion in chemical biology, 2011 - Elsevier
Redox homeostasis is frequently dysregulated in human disease, particularly cancer.
Recent and ongoing efforts seek to validate and extend this platform for the discovery …

Cellular redox pathways as a therapeutic target in the treatment of cancer

AJ Montero, J Jassem - Drugs, 2011 - Springer
The vulnerability of some cancer cells to oxidative signals is a therapeutic target for the
rational design of new anticancer agents. In addition to their well characterized effects on …

Role of protein S-Glutathionylation in cancer progression and development of resistance to anti-cancer drugs

D Pal, A Rai, R Checker, RS Patwardhan… - Archives of Biochemistry …, 2021 - Elsevier
The survival, functioning and proliferation of mammalian cells are highly dependent on the
cellular response and adaptation to changes in their redox environment. Cancer cells often …

Multifaceted roles of glutathione and glutathione-based systems in carcinogenesis and anticancer drug resistance

E Hatem, N El Banna, ME Huang - Antioxidants & redox signaling, 2017 - liebertpub.com
Significance: Glutathione is the most abundant antioxidant molecule in living organisms and
has multiple functions. Intracellular glutathione homeostasis, through its synthesis …

Novel strategies for targeting the thioredoxin system for cancer therapy

Q Xu, J Zhang - Expert Opinion on Drug Discovery, 2022 - Taylor & Francis
Introduction The thioredoxin system is increasingly recognized as an important executor for
maintaining cell redox homeostasis and regulating multiple cell signaling pathways …

The redox regulation of thiol dependent signaling pathways in cancer

GI Giles - Current pharmaceutical design, 2006 - ingentaconnect.com
Reactive oxygen species (ROS) play a central role as second messengers in many signal
transduction pathways, where they can post-translationally modify proteins via the oxidation …

Redox-directed cancer therapeutics: molecular mechanisms and opportunities

GT Wondrak - Antioxidants & redox signaling, 2009 - liebertpub.com
Redox dysregulation originating from metabolic alterations and dependence on mitogenic
and survival signaling through reactive oxygen species represents a specific vulnerability of …

Clinically evaluated cancer drugs inhibiting redox signaling

DL Kirkpatrick, G Powis - Antioxidants & redox signaling, 2017 - liebertpub.com
Significance: There are a number of redox-active anticancer agents currently in
development based on the premise that altered redox homeostasis is necessary for cancer …

Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation

KD Tew - Biochemical pharmacology, 2007 - Elsevier
Glutathione (GSH) provides a major source of thiol homeostasis critical to the maintenance
of a reduced cellular environment that is conducive to cell survival. Mammals have …

Thioredoxin and Glutathione Systems: Cancer Cells' Defensive Weapons Against Oxidative Stress

Y Yu, G Di Trapani, KF Tonissen - Handbook of Oxidative Stress in Cancer …, 2022 - Springer
Most cancer cells contain high levels of reactive oxygen species (ROS), which result in
higher expression levels of the glutathione and thioredoxin reductase systems. These …